Jessica E Smith, PA
Physician Assistant · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 19 years
- Graduated 2007
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jessica E Smith’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A54766 · Current
Licensed to practise in California · since 1995 · expires 2028-11-30 · Loma Linda University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$24,747
Medicare paid this office $24,747 for 208 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 102 | $7,643 | $67 |
| Return visit (30+ min) | 74 | $7,475 | $95 |
| Long return visit (40+ min) | 27 | $3,471 | $116 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,009 | $134 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
208 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 13% · Health risk score 0.87. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 57% · Coronary heart disease 18% · Diabetes 17% · Depression 17% · Chronic kidney disease 16% · Cancer 11% · Atrial fibrillation 11% · Heart failure 9% · COPD 8% · Stroke 6%.
The office billed $90,176, Medicare allowed $33,602 and paid $24,747; for 299 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 208 | 299 | 76 | 0.87 | $90,176 | $24,747 |
| 2023 | 181 | 237 | 76 | 0.81 | $71,830 | $19,767 |
| 2022 | 150 | 228 | 74 | 0.70 | $60,262 | $19,370 |
| 2021 | 96 | 135 | 73 | 0.71 | $32,566 | $11,177 |
| 2020 | 109 | 156 | 74 | 0.84 | $33,525 | $7,783 |
| 2019 | 206 | 296 | 76 | 0.92 | $77,716 | $18,348 |
| 2018 | 201 | 260 | 76 | 0.84 | $65,760 | $15,165 |
| 2017 | 57 | 104 | 72 | 1.08 | $13,935 | $3,754 |
| 2016 | 123 | 139 | 72 | 0.85 | $13,716 | $3,438 |
| 2015 | 162 | 199 | 72 | 0.87 | $13,354 | $5,280 |
| 2014 | 124 | 147 | 72 | 0.86 | $7,843 | $3,591 |
| 2013 | 22 | 23 | 72 | 0.79 | $1,395 | $679 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 46 | $4,673 | $87 |
| Short return visit (20+ min) | 61 | $4,463 | $71 |
| Long return visit (40+ min) | 20 | $2,961 | $135 |
| New patient visit (30+ min) | 19 | $1,675 | $88 |
| New patient visit (15+ min) | 20 | $1,086 | $54 |
2022: 4 services
| Return visit (30+ min) | 73 | $7,091 | $88 |
| Short return visit (20+ min) | 50 | $3,287 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,282 | $137 |
| Long return visit (40+ min) | 14 | $1,882 | $134 |
2021: 2 services
| Return visit (30+ min) | 40 | $4,435 | $103 |
| Short return visit (20+ min) | 48 | $3,697 | $71 |
2020: 2 services
| Return visit (30+ min) | 58 | $3,771 | $60 |
| Short return visit (20+ min) | 36 | $1,704 | $47 |
2019: 2 services
| Return visit (30+ min) | 159 | $12,952 | $72 |
| Short return visit (20+ min) | 51 | $3,156 | $53 |
2018: 2 services
| Return visit (30+ min) | 123 | $9,092 | $70 |
| Short return visit (20+ min) | 83 | $3,992 | $45 |
2017: 2 services
| Return visit (30+ min) | 34 | $2,159 | $63 |
| Short return visit (20+ min) | 16 | $716 | $45 |
2016: 2 services
| Short return visit (20+ min) | 87 | $2,138 | $23 |
| New patient visit (15+ min) | 18 | $460 | $26 |
2015: 4 services
| Short return visit (20+ min) | 122 | $3,708 | $27 |
| Return visit (30+ min) | 13 | $585 | $45 |
| New patient visit (15+ min) | 20 | $468 | $23 |
| Short return visit | 14 | $208 | $14 |
2014: 3 services
| Short return visit (20+ min) | 84 | $2,300 | $25 |
| Return visit (30+ min) | 13 | $552 | $42 |
| Short return visit | 22 | $241 | $10 |
2013: 1 service
| Short return visit (20+ min) | 15 | $440 | $29 |
Drugs they prescribed that Part D paid
$10,528
Pharmacies billed $10,528 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
229 generic and fewer than 11 brand-name prescriptions · $10,528 in drug cost · 29 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 11 | $266 | $24 |
| Amlodipine Besylate | 12 | $70 | $6 |
| Paxlovid | 21 | $0 | $0 |
Year by year
| 2024 | 277 | 131 | None | None | $10,528 |
| 2023 | 199 | 101 | 0% (0) | 7% | $6,683 |
| 2022 | 207 | 91 | None | None | $14,900 |
| 2021 | 125 | 69 | None | 14% | $9,244 |
| 2020 | 186 | 75 | None | None | $9,495 |
| 2019 | 230 | 117 | None | 17% | $11,177 |
| 2018 | 175 | 101 | None | 26% | $9,094 |
| 2017 | 68 | 46 | None | None | $1,727 |
| 2016 | 225 | 105 | None | 13% | $5,019 |
| 2015 | 254 | 123 | 7% (18) | 17% | $7,577 |
| 2014 | 467 | 130 | None | None | $19,804 |
| 2013 | 2,119 | 134 | 5% (96) | 21% | $96,957 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Lisinopril | 17 | $269 | $16 |
| Paxlovid (Eua) | 25 | $258 | $10 |
| Atorvastatin | 12 | $184 | $15 |
2022: 2 drugs
| Atorvastatin | 18 | $276 | $15 |
| Lisinopril | 17 | $106 | $6 |
2020: 1 drug
| Levothyroxine | 14 | $369 | $26 |
2019: 2 drugs
| Atorvastatin | 11 | $221 | $20 |
| Azithromycin | 12 | $95 | $8 |
2018: 1 drug
| Proair Hfa | 16 | $1,024 | $64 |
2016: 4 drugs
| Triamcinolone Acetonide | 13 | $309 | $24 |
| Fluticasone Propionate | 11 | $247 | $22 |
| Losartan | 11 | $153 | $14 |
| Polyethylene Glycol 3350 | 13 | $137 | $11 |
2015: 6 drugs
| Levothyroxine | 16 | $290 | $18 |
| Hydrocodone-Acetaminophen | 13 | $110 | $8 |
| Azithromycin | 11 | $92 | $8 |
| Ciprofloxacin | 14 | $87 | $6 |
| Naproxen | 12 | $77 | $6 |
| Prednisone | 13 | $65 | $5 |
2014: 10 drugs
| Nexium | 11 | $2,702 | $246 |
| Metoprolol | 14 | $858 | $61 |
| Levothyroxine | 36 | $583 | $16 |
| Omeprazole | 14 | $427 | $31 |
| Gabapentin | 13 | $209 | $16 |
| Simvastatin | 35 | $205 | $6 |
| Lisinopril | 12 | $155 | $13 |
| Lamotrigine | 14 | $112 | $8 |
| Ranitidine | 14 | $80 | $6 |
| Trazodone | 11 | $39 | $4 |
2013: 62 drugs
| Crestor | 35 | $7,415 | $212 |
| Nexium | 29 | $6,488 | $224 |
| Humalog | 14 | $4,087 | $292 |
| Lantus Solostar | 13 | $3,219 | $248 |
| Advair Diskus | 11 | $3,016 | $274 |
| Quetiapine | 46 | $2,966 | $64 |
| Lyrica | 11 | $2,838 | $258 |
| Benicar | 15 | $2,747 | $183 |
| Buspirone | 16 | $2,019 | $126 |
| Metoprolol | 36 | $1,986 | $55 |
| Dexilant | 12 | $1,896 | $158 |
| Vytorin | 11 | $1,866 | $170 |
| Clomipramine | 12 | $1,843 | $154 |
| Omeprazole | 68 | $1,750 | $26 |
| Divalproex Sodium Er | 12 | $1,539 | $128 |
| Gabapentin | 40 | $1,461 | $37 |
| Fenofibrate | 11 | $1,304 | $119 |
| Pioglitazone | 22 | $1,131 | $51 |
| Levothyroxine | 111 | $1,004 | $9 |
| Fenofibrate | 12 | $887 | $74 |
| Simvastatin | 81 | $769 | $9 |
| Glipizide Xl | 42 | $739 | $18 |
| Hydrocodone-Acetaminophen | 33 | $598 | $18 |
| Lisinopril | 67 | $595 | $9 |
| Risperidone | 12 | $556 | $46 |
| Proair Hfa | 11 | $533 | $48 |
| Paroxetine | 35 | $497 | $14 |
| Metformin | 50 | $492 | $10 |
| Verapamil Er | 24 | $425 | $18 |
| Pravastatin | 17 | $421 | $25 |
| Lamotrigine | 53 | $354 | $7 |
| Alendronate | 32 | $351 | $11 |
| Methotrexate | 12 | $347 | $29 |
| Losartan | 21 | $337 | $16 |
| Tramadol | 37 | $328 | $9 |
| Atorvastatin | 12 | $308 | $26 |
| Hydrochlorothiazide | 60 | $296 | $5 |
| Oxybutynin Chloride | 15 | $269 | $18 |
| Lisinopril-Hydrochlorothiazide | 31 | $261 | $8 |
| Ranitidine | 34 | $260 | $8 |
| Amlodipine Besylate | 30 | $255 | $8 |
| Fluvoxamine Maleate | 12 | $238 | $20 |
| Warfarin | 24 | $237 | $10 |
| Fluoxetine | 11 | $231 | $21 |
| Sertraline | 23 | $215 | $9 |
| Mirtazapine | 19 | $208 | $11 |
| Metoprolol | 43 | $197 | $5 |
| Prednisone | 18 | $192 | $11 |
| Prenatal Plus | 29 | $190 | $7 |
| Benazepril | 14 | $189 | $14 |
| Ibuprofen | 29 | $181 | $6 |
| Trazodone | 40 | $176 | $4 |
| Atenolol | 27 | $175 | $6 |
| Citalopram Hbr | 23 | $172 | $7 |
| Hydroxyzine Pamoate | 13 | $167 | $13 |
| Glimepiride | 12 | $150 | $12 |
| Benztropine Mesylate | 12 | $129 | $11 |
| Meloxicam | 14 | $114 | $8 |
| Enalapril Maleate | 14 | $91 | $7 |
| Amitriptyline | 33 | $86 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $73 | $6 |
| Furosemide | 15 | $61 | $4 |
Money from drug and device companies
$139 in 2022
A payment is not proof that care is biased.
| Tactile Systems Technology | Flexitouch Plus | $139 | 1 payment
|
See the published payment
| Tactile Systems Technology | Meals · 2022-10-20 | Flexitouch Plus | $139 |
Professional record
- NPI
- 1760685051
- Licence
- CA 54766California A54766: Current · expires 2028-11-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- ID 1760685051
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-06-06
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Forest St, Mccall, ID, 83638